Prosecution Insights
Last updated: August 15, 2026

Florida State University Research Foundation Inc.

9 pending office actions • 7 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 17 patents granted in the last 365 days

Portfolio Summary

9
Total Pending OAs
5
Non-Final OAs
2
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (33%)
4
Medium (44%)
2
Easy (22%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (11%)
§103 only3 (33%)
§102 only1 (11%)
§112 only1 (11%)
Double-patenting only1 (11%)
Multi-statute (no §101)2 (22%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
56% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
22% of docket
2
Business / Other
22% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

90 h
Manual time on pending OAs
18 h
Time saved (low, 20%)
31 h
Time saved (mid, 35%)
0.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MALLEY JR., DANIEL PATRICK 1 56.8% +45.3%
HUTTER, GILLIAN A 1 54.2% +46.9%
FERREIRA, CATHERINE M 1 39.1% +33.0%
KEELING, ALEXANDER W 1 56.4% +37.7%
RAO, SAVITHA M 1 60.6% +30.0%
BAUM, ZACHARY JOHN 1 81.6% +15.0%
BANKS, KEONA LAUREN 1 55.9% +1.6%
BRISTOL, LYNN ANNE 1 63.6% +39.7%
KAPUSHOC, STEPHEN THOMAS 1 46.7% +53.2%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18506745 PULSE SHAPING BURST MODE GAS/LIQUID/PLASMA REACTOR BAUM, ZACHARY JOHN
18472466 METHODS OF IN SITU OPTICAL ANALYSIS OF SYRINGES AND SYSTEMS BANKS, KEONA LAUREN
18300477 Molecular Biomarkers for Predicting Patient Response to Steroid Therapy KAPUSHOC, STEPHEN THOMAS

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18960568 ORGANIC PHOTOVOLTAIC MATERIALS, DEVICES, AND METHODS MALLEY JR., DANIEL PATRICK 5d overdue
18825099 DOUBLE NURSING BRA CLIP FERREIRA, CATHERINE M 28d
18901200 SELECTIVE TREATMENT OF CANCERS HAVING HISTONE H3 MUTATIONS OR ABERRANT LEVELS OF DNA OR HISTONE METHYLATION, ACETYLATION OR DEFECTS IN HOMOLOGOUS RECOMBINATION HUTTER, GILLIAN A
18433570 BIMETALLIC IRON-COBALT NANOCARBIDE ELECTROCATALYSTS FOR THE OXYGEN EVOLUTION REACTION KEELING, ALEXANDER W
18398315 THERAPEUTICS FOR KELOIDS AND OTHER FIBROTIC DISORDERS RAO, SAVITHA M
18506745 PULSE SHAPING BURST MODE GAS/LIQUID/PLASMA REACTOR BAUM, ZACHARY JOHN
18320272 CYTOSOLIC MICROPARTICLES, PHAGOCYTIC CELLS COMPRISING THE SAME, AND METHODS FOR TREATING DISEASE COMPRISING THE SAME BRISTOL, LYNN ANNE
18300477 Molecular Biomarkers for Predicting Patient Response to Steroid Therapy KAPUSHOC, STEPHEN THOMAS

Top Art Units

Art UnitApps
1726 1
3732 1
1691 1
1736 1
3763 1
1643 1
1683 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18960568 ORGANIC PHOTOVOLTAIC MATERIALS, DEVICES, AND METHODS MALLEY JR., DANIEL PATRICK 1726 §103 Final Rejection 5d overdue Pending Nov 26, 2024
18901200 SELECTIVE TREATMENT OF CANCERS HAVING HISTONE H3 MUTATIONS OR ABERRANT LEVELS OF DNA OR HISTONE METHYLATION, ACETYLATION OR DEFECTS IN HOMOLOGOUS RECOMBINATION HUTTER, GILLIAN A DP Non-Final OA Pending Sep 30, 2024
18825099 DOUBLE NURSING BRA CLIP FERREIRA, CATHERINE M 3732 §102 Non-Final OA 28d Pending Sep 05, 2024
18433570 BIMETALLIC IRON-COBALT NANOCARBIDE ELECTROCATALYSTS FOR THE OXYGEN EVOLUTION REACTION KEELING, ALEXANDER W §103 Non-Final OA Pending Feb 06, 2024
18398315 THERAPEUTICS FOR KELOIDS AND OTHER FIBROTIC DISORDERS RAO, SAVITHA M 1691 §103 Non-Final OA Pending Dec 28, 2023
18506745 PULSE SHAPING BURST MODE GAS/LIQUID/PLASMA REACTOR BAUM, ZACHARY JOHN 1736 §102§103 Non-Final OA Pending Nov 10, 2023
18472466 METHODS OF IN SITU OPTICAL ANALYSIS OF SYRINGES AND SYSTEMS BANKS, KEONA LAUREN 3763 §102§103§112 Non-Final OA Pending Sep 22, 2023
18320272 CYTOSOLIC MICROPARTICLES, PHAGOCYTIC CELLS COMPRISING THE SAME, AND METHODS FOR TREATING DISEASE COMPRISING THE SAME BRISTOL, LYNN ANNE 1643 §112 Non-Final OA Pending May 19, 2023
18300477 Molecular Biomarkers for Predicting Patient Response to Steroid Therapy KAPUSHOC, STEPHEN THOMAS 1683 §101§102§112 Final Rejection Pending Apr 14, 2023

Managing Florida State University Research Foundation Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month